SynthesisPloS one2015

Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.

Cecilia Bosco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.